Display options
Cite
Cao J, An Q, Wang L. Pediatric sarcomas. Oncol Lett. 2017;15(2):1397-1402doi: 10.3892/ol.2017.7467.
Cao, J., An, Q., & Wang, L. (2018). Pediatric sarcomas. Oncology letters, 15(2), 1397-1402. https://doi.org/10.3892/ol.2017.7467
Cao, Junhua, et al. "Pediatric sarcomas." Oncology letters vol. 15,2 (2018): 1397-1402. doi: https://doi.org/10.3892/ol.2017.7467
Cao J, An Q, Wang L. Pediatric sarcomas. Oncol Lett. 2018 Feb;15(2):1397-1402. doi: 10.3892/ol.2017.7467. Epub 2017 Nov 21. PMID: 29434830; PMCID: PMC5776166.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2018 Feb;15(2):1397-1402. doi: 10.3892/ol.2017.7467. Epub 2017 Nov 21.

Pediatric sarcomas.

Oncology letters

Junhua Cao, Qi An, Lei Wang

Affiliations

  1. Department of Pediatric Internal Medicine, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, P.R. China.

PMID: 29434830 PMCID: PMC5776166 DOI: 10.3892/ol.2017.7467

Abstract

Sarcomas arise from primitive mesenchymal cells, which are classified, into two main groups: Bone and soft tissue sarcomas. We have searched all-important electronic databases including Google scholar and PubMed for the collection of latest literature pertaining to pediatric sarcomas. Latest literature confirmed that these tumors are relatively rare and represent only 1% of all malignancies but they have higher incidence in children. Pediatric sarcomas comprise about 13% of all pediatric malignancies and are ranked third in childhood cancers. The highest incidence rates are reported among rhabdomyosarcoma, osteosarcoma and Ewing's sarcomas in children. All of these neoplasms often display highly aggressive behavior with tendency to form metastases. Important globally used management avenues include surgery with systemic chemotherapy and have success rate of 70% at 5-years. Furthermore, in the cases of advanced stages, the prognosis is poor, chances of treatment failure and recurrence are quite high. Utilization of cancer stem cells is the latest approach with great potential in management of above pathological state. The present review article discuss all-important aspects of commonly found pediatric sarcomas throughout the world.

Keywords: osteosarcoma; pediatric; rhabdomyosarcoma; sarcomas

References

  1. Oncogene. 2012 Jun 21;31(25):3009-22 - PubMed
  2. Oncogene. 2013 Sep 5;32(36):4252-63 - PubMed
  3. Cancer Lett. 2016 Jan 28;370(2):286-95 - PubMed
  4. Oncogene. 2008 Jun 26;27(28):3923-34 - PubMed
  5. Cancer Res. 2009 Dec 1;69(23):9047-55 - PubMed
  6. Cancer. 2014 Sep 1;120(17 ):2766-77 - PubMed
  7. Pediatr Blood Cancer. 2013 Jan;60(1):45-52 - PubMed
  8. J Cancer Ther. 2014 Mar 31;5(4):331-338 - PubMed
  9. Stem Cells. 2016 Jan;34(1):246-51 - PubMed
  10. Front Oncol. 2013 Apr 15;3:81 - PubMed
  11. Front Oncol. 2013 Jun 27;3:168 - PubMed
  12. Neoplasia. 2005 Nov;7(11):967-76 - PubMed
  13. Int J Mol Sci. 2013 Dec 31;15(1):423-37 - PubMed
  14. Oncol Rep. 2014 Aug;32(2):845-52 - PubMed
  15. J Cell Physiol. 2009 May;219(2):301-13 - PubMed
  16. Skelet Muscle. 2012 Dec 03;2(1):25 - PubMed
  17. Lancet Oncol. 2017 Mar;18(3):e166-e175 - PubMed
  18. F1000Prime Rep. 2015 Feb 03;7:14 - PubMed
  19. BMC Cancer. 2014 Sep 05;14:654 - PubMed
  20. Cancer Cell. 2011 Feb 15;19(2):177-91 - PubMed
  21. Cancer Res. 2008 Aug 15;68(16):6587-97 - PubMed
  22. Pancreas. 2016 Jan;45(1):117-22 - PubMed
  23. Pediatr Blood Cancer. 2016 Jan;63(1):47-53 - PubMed
  24. Cancer Res. 2010 Jun 1;70(11):4602-12 - PubMed
  25. Future Oncol. 2017 Feb;13(4):357-368 - PubMed
  26. BMC Cancer. 2006 Feb 02;6:32 - PubMed
  27. PLoS One. 2015 Apr 27;10(4):e0125454 - PubMed
  28. Asian Pac J Cancer Prev. 2013;14(9):5403-8 - PubMed
  29. Int J Clin Exp Pathol. 2015 Oct 01;8(10 ):12084-92 - PubMed
  30. Cancer Res. 2009 Mar 1;69(5):1776-81 - PubMed
  31. Cancer Med. 2014 Aug;3(4):796-811 - PubMed
  32. CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29 - PubMed
  33. Br J Cancer. 2009 Dec 15;101(12):2030-7 - PubMed
  34. Int J Cancer. 2010 Sep 1;127(6):1295-307 - PubMed
  35. Curr Oncol Rep. 2014;16(8):395 - PubMed
  36. N Engl J Med. 2014 Sep 11;371(11):1039-49 - PubMed
  37. Cancer Treat Rev. 2014 May;40(4):523-32 - PubMed
  38. Cancer Cell. 2007 May;11(5):421-9 - PubMed
  39. PLoS One. 2008;3(10 ):e3469 - PubMed
  40. Genes Dev. 2010 May;24(9):916-32 - PubMed
  41. J Cell Physiol. 2016 Apr;231(4):876-86 - PubMed
  42. Clin Transl Med. 2014 Jul 04;3:19 - PubMed
  43. Nat Commun. 2015 Apr 02;6:6411 - PubMed
  44. FASEB J. 2011 Jun;25(6):2022-30 - PubMed
  45. Cell. 2009 May 15;137(4):647-58 - PubMed
  46. Lancet Oncol. 2010 Feb;11(2):184-92 - PubMed
  47. PLoS One. 2015 Jun 19;10(6):e0130192 - PubMed
  48. Cancer Sci. 2011 Oct;102(10 ):1774-81 - PubMed
  49. Biochim Biophys Acta. 2014 Jun;1843(6):1225-36 - PubMed
  50. Gut. 2008 Nov;57(11):1555-60 - PubMed
  51. J Histochem Cytochem. 2011 Apr;59(4):441-55 - PubMed
  52. Int J Cancer. 2011 Jan 15;128(2):294-303 - PubMed

Publication Types